Aescap Venture is a visionary Amsterdam-based biotech, medical, healthcare, and cleantech investment company specialising in early stage, seed, and expansion capital for innovative life sciences ventures. The firm typically invests in private companies in Europe, but its portfolio also extends to the U.S. and their medical professionals onboard keep the team well informed. With a general exit strategy of between three and seven years, Aescap assures further success by co-investing in subsequent rounds of funding. We are delighted to award Aescap Venture Best Life Sciences Investment Team for Europe, 2016.
